Study of Chemoradiotherapy in Oesophageal Cancer Including PET Response and Dose Escalation

NCT02741856 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

584

Enrollment

OTHER_GOV

Sponsor class

Conditions

Oesophageal Cancer

Interventions

DRUG: Carboplatin
DRUG: Paclitaxel
DRUG: Cisplatin
DRUG: Capecitabine
RADIATION: Radiotherapy

Sponsor

Lisette Nixon

Collaborators

[object Object]